The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03118687
Recruitment Status :
First Posted : April 18, 2017
Last Update Posted : February 8, 2021
Vanderbilt University Medical Center
Human Vaccines Project
Information provided by (Responsible Party):
James E. Crowe, Jr., Vanderbilt University Medical Center
The Human Immunome Program is a large-scale, open-source effort seeking to fill a major gap in our knowledge of the immune system. The power of the immune system to fight disease lies in its ability recognize and adapt to an astonishing range of threats from viruses, parasites and bacteria to cancer cells. Underlying this ability is a vast but specific set of genes and molecular structures known as the human immunome, or the "parts list" of the immune system. This study aims to decipher the genetic sequences that make up this part list and link it to information about a person's microbiome composition and characteristics such as health history, race, and demographics over time. This information, made freely available to the public for use in research in de-identified form, will allow investigators to answer a wide variety of different questions about immune system function. This could transform how we diagnose, prevent and treat disease though the identification of new biomarkers while enabling highly targeted, computationally designed vaccines and therapies that reduce time and risk of product development.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 49 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Healthy adult volunteers
Healthy male and female volunteers between the ages of 18 - 49 years of age at the time of first enrollment.
Ability to comply: Participant willing and able to comply with the requirements of the protocol.
Consent: Participants who have given informed consent for participation in the study
Reason for exclusion throughout the entire study period:
History of severe anemia requiring blood transfusion or current Hemoglobin < 10g/dL.
Currently pregnant or pregnancy within 6 months.
Current participation in another study resulting in blood collection which exceeds 550 ml in an 8 week period or occurs more frequently than 2 times per week.
Any condition which, in the opinion of the investigator, might interfere with study objectives.
Any reason which, in the opinion of the investigator, adds additional risk to the patient.
Reason for exclusion in year 0 but not in year 1-9:
History of known HIV infection or treatment.
Immunosuppressive disease or use of systemic immunosuppressive therapy using drugs or cytotoxic agents including prednisone (IV, oral or inhaled) less than 6 months ago.
History of diabetes mellitus -or a glucose (on CMP) ≥200 mg/dL.